| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lansoprazole | FAERS: 70 | US FAERS | |
| 2 | Alendronate | FAERS: 6 | US FAERS | |
| 3 | rofecoxib | FAERS: 6 | US FAERS | |
| 4 | Methotrexate | FAERS: 3 | US FAERS | |
| 5 | Rosiglitazone | FAERS: 3 | US FAERS | |
| 6 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 7 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 8 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 9 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 10 | Amlodipine | FAERS: 1 | US FAERS | |
| 11 | Benicar hct | FAERS: 1 | US FAERS | |
| 12 | Celecoxib | FAERS: 1 | US FAERS | |
| 13 | Clofarabine | FAERS: 1 | US FAERS | |
| 14 | Clomiphene | FAERS: 1 | US FAERS | |
| 15 | Diovan Hct | FAERS: 1 | US FAERS | |
| 16 | Finasteride | FAERS: 1 | US FAERS | |
| 17 | Levetiracetam | FAERS: 1 | US FAERS | |
| 18 | Liraglutide | FAERS: 1 | US FAERS | |
| 19 | Lisinopril | FAERS: 1 | US FAERS | |
| 20 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 21 | Prednisolone | FAERS: 1 | US FAERS | |
| 22 | Pseudoephedrine | FAERS: 1 | US FAERS | |
| 23 | Ritonavir | FAERS: 1 | US FAERS | |
| 24 | Testosterone | FAERS: 1 | US FAERS | |
| 25 | Thyroxine | FAERS: 1 | US FAERS | |
| 26 | Valsartan | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | ambrisentan | FAERS: 1 | US FAERS | |
| 28 | teriflunomide | FAERS: 1 | US FAERS | |
| 29 | Icodextrin | SIDER | ||
| 30 | Resveratrol | 21054406 | CTD | |
| 31 | Tacrolimus | SIDER | ||
| 32 | cobaltiprotoporphyrin | 22193921 | CTD |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.